Zdrowie i gospodarka · 14/06/2002

FDA Releases Draft Guidance on Stability Data Evaluation for Pharmaceuticals

The Food and Drug Administration (FDA) has made available a draft guidance document titled 'Q1E Evaluation of Stability Data' under the International Conference on Harmonisation (ICH), which provides guidance on using stability data to determine retest periods and shelf lives for pharmaceuticals.